Health Action Leader to Have a Presence at HLTH 2023, MHPA23 and the NCQA Health Innovation Summit
MINNEAPOLIS, Sept. 19, 2023 (GLOBE NEWSWIRE) — Icario, the healthcare industry’s leading engagement company, today announced its plans to attend three key industry events in October: HLTH 2023 in Las Vegas, MHPA23 in National Harbor (near Washington, D.C.), and the NCQA Health Innovation Summit in Orlando. The Icario Team will be actively on-site and welcomes the ability to network, demonstrate, and discuss how Icario is shaping, delivering and driving the next generation of healthcare.
HLTH 2023
MHPA23
NCQA Health Innovation Summit
About Icario
Icario is the leading digital-first health action company driving the next generation of healthcare. Powering over 100 million connections with people, the company’s health action platform unites whole-person data, behavioral science, and digital-first omnichannel pathways to personally connect everyone to health. Icario deeply understands people and delivers personalization at scale for the most trusted healthcare organizations in all 50 states, including eight of the 10 largest health plans. Learn more at www.icariohealth.com.
BOCA Communications for Icario
icario@bocacommunications.com
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…